Skip to main content
Clinical Trials/ISRCTN11195489
ISRCTN11195489
Active, not recruiting
未知

nderstanding Brain Inflammation in Cognitive Problems (BRIC)

ewcastle upon Tyne Hospitals NHS Foundation Trust0 sites110 target enrollmentJuly 9, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Dementia with Lewy bodies
Sponsor
ewcastle upon Tyne Hospitals NHS Foundation Trust
Enrollment
110
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 9, 2024
End Date
September 1, 2029
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
ewcastle upon Tyne Hospitals NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • MCI\-LB/DLB group:
  • 1\. Age \=60 years
  • 2\. Fulfil criteria for probable MCI\-LB (McKeith et al., 2020\) or DLB (McKeith et al., 2017\)
  • 3\. Capacity to consent to participation in the study
  • 4\. MMSE \=20
  • 5\. If on cholinesterase inhibitors and/or memantine, stable dose for 3 months
  • Control group:
  • 1\. Age \=60 years
  • 2\. MMSE \=27
  • 3\. No evidence of mild cognitive impairment or dementia

Exclusion Criteria

  • 1\. Active systemic inflammatory disease
  • 2\. Active autoimmune disease
  • 3\. Taking immune system modifying medications (e.g., oral steroids or tumour necrosis factor inhibitors)
  • 4\. Taking incretin analogues (e.g., liraglutide), minocycline or other microglial suppressing agents
  • 5\. History of clinical stroke
  • 6\. Current major depression
  • 7\. History of bipolar disorder, non\-organic psychosis (e.g., longstanding schizophrenia) or recurrent severe depression
  • 8\. Chronic migraine

Outcomes

Primary Outcomes

Not specified

Similar Trials